Pain Relief
Natural health product licensed in Canada
- Licence holder
- Lerapharm Inc.
- NPN or DIN-HM
- 80096855
- Status
- Active licence
- Licence date
- 28 January 2020
- Revision date
- Not provided
- Form
- Liquides
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Tanacetum parthenium Source : Feuille Extract : Matériel brut sec Extraction ratio : 40:1 Dry plant equivalent : 25 mg | 0.625 mg | Not calculated |
| Harpagophytum procumbens Source : Racine(s) secondaire(s) tubérisée(s) Extract : Matériel brut sec Extraction ratio : 3.333:1 Dry plant equivalent : 300 mg | 90 mg | Not calculated |
| Scutellaria lateriflora Source : Sommité Extract : Matériel brut sec Extraction ratio : 7.997:1 Dry plant equivalent : 125 mg | 15.63 mg | Not calculated |
| Zingiber officinale Source : Rhizome Extract : Matériel brut sec Extraction ratio : 6.667:1 Dry plant equivalent : 150 mg | 22.5 mg | Not calculated |
Non-medicinal ingredients
Ethanol, Xylitol, Glycérine, Acide citrique, Eau
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 mL | 1 Tous les jours |
Uses authorised in Canada
Used in Herbal Medicine to help relieve joint pain associated with osteoarthritis. Feverfew is traditionally used in Herbal Medicine to help relieve headaches. Skullcap is traditionally used in Herbal Medicine to help relieve the pain associated with menstruation (antispasmodic).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
- Consult a health care practitioner prior to use if symptoms persist or worsen. - Consult a health care practitioner prior to use if you are taking blood thinners. - Avoid taking with alcohol or products that cause drowsiness.
- Contre-indications
- Do not use this product if you are pregnant or breastfeeding.
- Effets indésirables connus
- Do not use if you are allergic to plants of the Asteraceae/Compositae/Daisy family. - Hypersensitivity, such as allergy, has been known to occur; in which case, discontinue use immediately. - Some people may experience sore mouth, mouth ulcers and/or gastrointestinal discomfort. - Some people may experience drowsiness. Exercise caution if operating heavy machinery, driving a motor vehicle or involved in activities requiring mental alertness.
Source
Official Health Canada record, licence 80096855
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.